Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

In today’s ACT Brief, we look at how artificial intelligence is reshaping drug development decisions across pharma, discuss ...

Artificial intelligence (AI) for science has rapidly gained momentum at an extreme pace. Models trained on the scientific record are generating hypotheses and even running experiments in automated ...

The pharmaceutical industry widely uses antibodies to create drugs, such as for cancer and coronaviruses. But creating the ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

Eli Lilly expanded its AI drug discovery pact with XtalPi to antibodies. Celltrion in-licensed two innovative autoimmune ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

The Accreditation Council for Medical Affairs (ACMA) is raising the bar for excellence in life sciences by incorporating artificial intelligence training into its flagship certification, The Board ...

An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea. With help from artificial intelligence, MIT researchers have designed ...